Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Compound Lysine Hydrochloride and Zinc Gluconate Granules

Approval Number

国药准字H20083620

Company迪沙药业集团有限公司

Registration Date

October 12, 2021

Previous Approval Numbers

国药准字H20083620

Drug Information

Generic Name

赖氨葡锌颗粒

Brand Name

迪沙

Dosage Form

颗粒剂

Strength

每袋含盐酸赖氨酸125毫克、葡萄糖酸锌35毫克（相当于锌5毫克）

Drug Type

化学药品

Registration Date

October 12, 2021

Company Information

Applicant Company

Company Name迪沙药业集团有限公司

Company Address

威海经技区青岛南路-1-4号

Manufacturing Company

Company Name迪沙药业集团有限公司

Company Address

威海经济技术开发区崮山镇东安路399号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy